• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Dupilumab-induced serum sickness-like reaction: An unusual adverse effect in a patient with atopic eczema
 
  • Details
  • Full
Options
2021
Letter to the Editor
Title

Dupilumab-induced serum sickness-like reaction: An unusual adverse effect in a patient with atopic eczema

Title Supplement
Letter To The Editor
Author(s)
Treudler, Regina
Universität Leipzig
Delaroque, Nicolas  
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Puder, Marcus
epitopic GmbH Leipzig
Simon, Jan C.
Universität Leipzig
Szardenings, Michael  
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV  
DOI
10.1111/jdv.16782
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Keyword(s)
  • Dupilumab

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024